ExodusPoint Capital Management’s Global Cord Blood Corporation CO Stock Holding History

ExodusPoint Capital Management’s Portfolio CO Stock Details CO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-10,283	Closed	-$33K	–	2160
2020 Q1	$33K	Buy	+10,283	New	+$45K	﹤0.01%	988

Other funds holding CO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

ExodusPoint Capital Management's CO Position: Q2 2020 in Review

ExodusPoint Capital Management sold out of Global Cord Blood Corporation (CO) in Q2 2020, closing a stake of 10,283 shares — an estimated $33K sold.

ExodusPoint Capital Management first reported a position in CO in Q1 2020 and held it in 1 quarter. The position peaked at $33K in Q1 2020. 32 funds tracked by Wall St. Rank hold CO as of Q2 2020.

ExodusPoint Capital Management reported no remaining Global Cord Blood Corporation position as of Q2 2020 after selling out during the quarter.
ExodusPoint Capital Management sold 10,283 Global Cord Blood Corporation shares in Q2 2020, an estimated $33K.
ExodusPoint Capital Management first reported a position in Global Cord Blood Corporation in Q1 2020 and held it in 1 quarter.
ExodusPoint Capital Management's Global Cord Blood Corporation position peaked at $33K in Q1 2020.
32 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2020.

Based on ExodusPoint Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.